Immucor Lays SEC, Shareholder Actions To Rest

Law360, New York (September 28, 2007, 12:00 AM EDT) -- Immucor Inc. washed its hands this week of litigation that accused it of covering up its alleged involvement in a hospital bribery scandal in Italy, settling with the U.S. Securities and Exchange Commission and winning court approval of its $2.5 million deal with shareholders.

With its Thursday settlement with the SEC, which had accused it of Securities Exchange Act violations, the Norcross, Ga.-based blood transfusion instruments maker agreed to a cease-and-desist order but didn't have to pay any penalties. Chief executive Gioacchino De Chirico laid to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.